222 related articles for article (PubMed ID: 19688697)
1. Animal models and different therapies for treatment of retinitis pigmentosa.
Rivas MA; Vecino E
Histol Histopathol; 2009 Oct; 24(10):1295-322. PubMed ID: 19688697
[TBL] [Abstract][Full Text] [Related]
2. Inherited retinal degenerations: therapeutic prospects.
Delyfer MN; Léveillard T; Mohand-Saïd S; Hicks D; Picaud S; Sahel JA
Biol Cell; 2004 May; 96(4):261-9. PubMed ID: 15145530
[TBL] [Abstract][Full Text] [Related]
3. Retinitis pigmentosa.
Hamel C
Orphanet J Rare Dis; 2006 Oct; 1():40. PubMed ID: 17032466
[TBL] [Abstract][Full Text] [Related]
4. [Research progress of treatment strategies for retinitis pigmentosa].
Qian TW; Xu X
Zhonghua Yan Ke Za Zhi; 2017 Feb; 53(2):148-153. PubMed ID: 28260368
[TBL] [Abstract][Full Text] [Related]
5. Tracing the progression of retinitis pigmentosa via photoreceptor interactions.
Camacho ET; Wirkus S
J Theor Biol; 2013 Jan; 317():105-18. PubMed ID: 23063618
[TBL] [Abstract][Full Text] [Related]
6. [Early therapeutic trials for retinitis pigmentosa].
Dufier JL
Bull Acad Natl Med; 2003; 187(9):1685-92; discussion 1692-4. PubMed ID: 15369238
[TBL] [Abstract][Full Text] [Related]
7. Concentric retinitis pigmentosa: clinicopathologic correlations.
Milam AH; De Castro EB; Smith JE; Tang WX; John SK; Gorin MB; Stone EM; Aguirre GD; Jacobson SG
Exp Eye Res; 2001 Oct; 73(4):493-508. PubMed ID: 11825021
[TBL] [Abstract][Full Text] [Related]
8. Long-term preservation of cone photoreceptors and visual acuity in rd10 mutant mice exposed to continuous environmental enrichment.
Barone I; Novelli E; Strettoi E
Mol Vis; 2014; 20():1545-56. PubMed ID: 25489227
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in treatment of retinitis pigmentosa.
He Y; Zhang Y; Su G
Curr Stem Cell Res Ther; 2015; 10(3):258-65. PubMed ID: 25345673
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Photoreceptor Death in Retinitis Pigmentosa.
Newton F; Megaw R
Genes (Basel); 2020 Sep; 11(10):. PubMed ID: 32987769
[TBL] [Abstract][Full Text] [Related]
11. On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention.
Farrar GJ; Kenna PF; Humphries P
EMBO J; 2002 Mar; 21(5):857-64. PubMed ID: 11867514
[TBL] [Abstract][Full Text] [Related]
12. Design and Development of AAV-based Gene Supplementation Therapies for Achromatopsia and Retinitis Pigmentosa.
Schön C; Becirovic E; Biel M; Michalakis S
Methods Mol Biol; 2018; 1715():33-46. PubMed ID: 29188504
[TBL] [Abstract][Full Text] [Related]
13. Patients and animal models of CNGβ1-deficient retinitis pigmentosa support gene augmentation approach.
Petersen-Jones SM; Occelli LM; Winkler PA; Lee W; Sparrow JR; Tsukikawa M; Boye SL; Chiodo V; Capasso JE; Becirovic E; Schön C; Seeliger MW; Levin AV; Michalakis S; Hauswirth WW; Tsang SH
J Clin Invest; 2018 Jan; 128(1):190-206. PubMed ID: 29202463
[TBL] [Abstract][Full Text] [Related]
14. Modeling Retinitis Pigmentosa with Patient-Derived iPSCs.
Leong YC; Sowden JC
Adv Exp Med Biol; 2023; 1415():555-563. PubMed ID: 37440086
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic strategies in RP (retinitis pigmentosa): light at the end of the tunnel?].
Abegg M; Hafezi F; Wenzel A; Grimm C; Remé CE
Klin Monbl Augenheilkd; 2000 Feb; 216(2):83-9. PubMed ID: 10730223
[TBL] [Abstract][Full Text] [Related]
16. A
Stanković D; Claudius AK; Schertel T; Bresser T; Uhlirova M
Dis Model Mech; 2020 Jun; 13(6):. PubMed ID: 32424050
[TBL] [Abstract][Full Text] [Related]
17. Genetically engineered large animal model for studying cone photoreceptor survival and degeneration in retinitis pigmentosa.
Petters RM; Alexander CA; Wells KD; Collins EB; Sommer JR; Blanton MR; Rojas G; Hao Y; Flowers WL; Banin E; Cideciyan AV; Jacobson SG; Wong F
Nat Biotechnol; 1997 Oct; 15(10):965-70. PubMed ID: 9335046
[TBL] [Abstract][Full Text] [Related]
18. [Retinitis pigmentosa: eye sight restoration by optogenetic therapy].
Roska B; Busskamp V; Sahel JA; Picaud S
Biol Aujourdhui; 2013; 207(2):109-21. PubMed ID: 24103341
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy restores vision and delays degeneration in the CNGB1(-/-) mouse model of retinitis pigmentosa.
Michalakis S; Koch S; Sothilingam V; Garcia Garrido M; Tanimoto N; Schulze E; Becirovic E; Koch F; Seide C; Beck SC; Seeliger MW; Mühlfriedel R; Biel M
Adv Exp Med Biol; 2014; 801():733-9. PubMed ID: 24664765
[TBL] [Abstract][Full Text] [Related]
20. Antioxidants slow photoreceptor cell death in mouse models of retinitis pigmentosa.
Komeima K; Rogers BS; Campochiaro PA
J Cell Physiol; 2007 Dec; 213(3):809-15. PubMed ID: 17520694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
